Find Academic Supervisors

Angelica Lindén Hirschberg is a Professor of Obstetrics and Gynecology (specializing in reproductive medicine) at Karolinska Institutet and a Senior Consultant in gynecological endocrinology at Karolinska University Hospital. She holds dual roles in academic leadership and clinical practice, focusing on disorders of reproductive function, endocrine-metabolic dysfunction, and hormonal conditions in women. Her affiliations include the Department of Women’s and Children’s Health, Reproductive Endocrinology and Metabolism Research Group, and the Division for Neonatology, Obstetrics, Gynaecology, and Reproductive Health. Education and Career: MD (Karolinska Institutet, 1984) PhD (Karolinska Institutet, 1989) Professor in Obstetrics and Gynecology (2007) Board member of international societies (ISGE, EMAS) Research Focus: Her translational research spans PCOS, obesity-related reproductive dysfunction, premature ovarian insufficiency, and disorders of sex development. Projects include hormonal impacts on athletic performance, immune therapy for ovarian dysfunction, and endometrial cell biology. Collaborations involve national/international networks and clinical trials (e.g., PROBES trial). Publications: Recent work emphasizes PCOS pathophysiology, menopausal health, and hormonal interventions in athletes. Key trends include single-cell profiling of endometrium, immunomodulatory therapies for POI, and non-hormonal treatments for vasomotor symptoms. Awards: King’s Seraphim Medal (2018) 2016 Grand Prize in Sport Science Appointed Royal Gynecologist (2009) Teaching and Mentorship: Coordinates courses on reproductive endocrinology, supervises PhD students (e.g., Esin Ylmaz), and chairs the PhD Study Director at her department. Authored over 25 book chapters on women’s health and sports medicine. Grants and Labs: Secured Swedish Research Council funding for POI trials. Her lab integrates experimental (Bioclinicum) and clinical (Women’s Health Research Unit) research.

• Reproductive Medicine
• Endocrinology
• Polycystic Ovary Syndrome (PCOS)
• +5 more

Andres Salumets is a Professor of Reproductive Medicine at the Department of Clinical Science, Intervention and Technology, Karolinska Institutet. His research focuses on molecular mechanisms underlying reproductive health, including endometrial biology, assisted reproduction technologies, and environmental influences on fertility. He leads studies on uterine fluid extracellular vesicles, genomic analysis of reproductive disorders, and the impact of endocrine disruptors on reproductive tissues. Salumets collaborates with multidisciplinary teams to translate findings into clinical applications, such as improving non-invasive prenatal testing (NIPT) and developing probiotics for male reproductive health. His work integrates cutting-edge technologies like AI-driven histology analysis, single-cell RNA sequencing, and genome-wide association studies (GWAS). Key research areas include polycystic ovary syndrome (PCOS), endometriosis, and recurrent implantation failure (RIF). Recent studies explore phthalate effects on endometrial cells and novel therapies for breast cancer using natural extracts. Salumets' research bridges basic science with clinical practice, aiming to enhance assisted reproduction outcomes and address global infertility challenges.

• Reproductive Medicine
• Medical Biotechnology
• Molecular Biology
• +3 more

Qiaolin Deng is an Associate Professor and Principal Researcher at the Department of Physiology and Pharmacology, Karolinska Institutet, Sweden. Her research group focuses on germ cell biology and developmental programming in epigenetic inheritance of diseases, particularly addressing how maternal health conditions like polycystic ovary syndrome (PCOS) and diabetes impact offspring health through placental and germline mechanisms. Her research integrates mouse disease models, human stem cell cultures (including induced pluripotent stem cells and placental organoids), single-cell sequencing (Smart-seq2, LCM-seq), and microfluidic co-culture systems to investigate molecular pathways in developmental programming. Key themes include epigenetic remodeling, X-chromosome dosage effects, and modeling of maternal disease signatures in offspring. Recent publications highlight her work on PCOS transgenerational effects, placental gene regulation, diabetes-related germline modifications, and advanced single-cell methodologies. She has secured prestigious grants including the Wallenberg Academy Fellow Grant, VR Consolidator Grant, and KIRI Fellow Grant, reflecting significant recognition in developmental biology and metabolic-reproductive medicine. Scientific Awards: KI Research Incubator (KIRI) Fellow postdoc grant (2022) Wallenberg Academy Fellow Grant (2019) Karolinska Institutet Consolidator Grant Swedish Research Council (VR) Consolidator Grant Young Investigator grants from Swedish Society for Medical Research, Swedish Medical Research Council, and KI Central Faculty Fund Her lab has trained numerous researchers, including PhD and master’s students, and collaborates with institutions such as UT Southwestern Medical Center, Tongji University, and Medical University of Vienna. Teaching contributions include EMBO courses on single-cell omics and advanced physiology lectures at Karolinska and Royal Institute of Technology.

• Cell and Molecular Biology
• Developmental Biology
• Endocrinology and Diabetes
• +2 more

Anna Benrick is an Associate Professor of Biomedicine at the University of Skövde's School of Health Sciences, where she has led her own research group since 2015. With over 20 years of experience in endocrinology, metabolism, and reproduction, her work focuses on the relationship between androgen excess and conditions including mental illness, reproductive disorders, obesity, and type 2 diabetes in women. She returned to academia in 2010 after completing a postdoctoral fellowship at the Garvan Institute for Medical Research, funded by the Swedish Research Council. Dr. Benrick's research program centers on polycystic ovary syndrome (PCOS), investigating underlying mechanisms and developing new treatment approaches. Her work spans multiple disciplines including endocrinology, metabolism, reproductive biology, and neuroscience, with particular emphasis on adiponectin signaling, transgenerational effects of androgen exposure, and metabolic complications of PCOS. Her laboratory employs diverse methodologies including animal models, proteomic analysis, clinical interventions, and molecular techniques to understand PCOS pathophysiology. Analysis of her recent publications reveals a strong focus on the interplay between hormonal imbalances and metabolic disorders, with increasing attention to transgenerational effects and immune system interactions in PCOS. Her work consistently bridges basic science with clinical applications, particularly in developing non-pharmacological interventions like electroacupuncture for PCOS management. As a dedicated educator and mentor, Dr. Benrick supervises doctoral students and regularly hosts research students in her laboratory. Her ongoing research project 'Obesity and androgen excess in women – adiponectin as a new treatment option' (2019-2021) exemplifies her translational approach to developing treatments that address both metabolic and reproductive aspects of PCOS. Her laboratory operates at the intersection of endocrinology and metabolism research, collaborating extensively with other researchers at the University of Skövde and internationally. The team combines expertise in molecular biology, animal physiology, and clinical research to address complex questions about PCOS pathogenesis and treatment.

• Endocrinology
• Metabolism
• Reproduction
• +7 more

Mikael Ryden is a Professor and Senior Physician at Karolinska Institutet, leading the Mikael Rydén & Niklas Mejhert lab within the Department of Medicine, Huddinge. He holds the title of Professor of Clinical and Experimental Fat Tissue Research and heads the Endocrinology Unit with a Lipid Laboratory, now part of the Center for Reproduction, Metabolism, and Molecular Medicine (CeRM). His research focuses on adipose tissue biology, lipid metabolism, and their roles in metabolic disorders such as obesity, type 2 diabetes, and atherosclerosis. Educated at Karolinska Institutet, Ryden earned his Medical Degree in 1996 and became a Docent in 2002. His work bridges clinical and experimental studies, investigating adipocyte function, immunometabolism, and epigenetic influences on metabolic health. Key achievements include uncovering adipose tissue's epigenetic memory post-weight loss and identifying molecular pathways linking obesity to inflammation and insulin resistance. Ryden has received prestigious awards, including the Camillo Golgi Prize, and leads grants like the Swedish Research Council-funded study on adipocyte lipid turnover. His lab collaborates internationally, with members specializing in molecular biology, clinical studies, and advanced proteomics. Current projects explore adipocyte heterogeneity, mitochondrial dysfunction in obesity, and therapeutic targets for metabolic diseases. Notable collaborations include work with Harvard University and Helmholtz Munich, contributing to platforms like the adiposetissue.org knowledge portal. Ryden supervises PhD students and mentors a team including research nurses, coordinators, and specialists in lab management and clinical trials.

• Endocrinology
• Diabetes Research
• Metabolic Disorders
• +3 more

Elisabet Stener-Victorin is a Professor at the Department of Physiology and Pharmacology, Karolinska Institutet, leading the Reproductive Endocrinology and Metabolism research group. Her work focuses on polycystic ovary syndrome (PCOS), exploring its genetic, epigenetic, and transgenerational transmission mechanisms. Key areas include immune dysfunction, metabolic comorbidities, and developmental programming. Education: PhD in Reproductive Endocrinology from the University of Gothenburg, followed by postdoctoral studies in Japan and a research position at Karolinska Institutet since 2015. Research interests include PCOS pathophysiology, transgenerational inheritance via germ cells, and clinical translation of findings. Techniques employed include single-cell sequencing, organoid modeling, and mouse models. Recent studies highlight immune dysregulation in PCOS and male transmission of metabolic risks. Grants and Awards: Distinguished Investigator Grant (2022) from Novo Nordisk Foundation, Swedish Research Council funding, and collaborations with international institutions like Monash University and Pennsylvania State University. Outreach: Active in media engagement (TV4, SVT) and podcasts (e.g., Metagenics Institute), emphasizing PCOS awareness. Supervised over a dozen PhD students, including Maria Manti and Romina Fornes. Labs/Teams: Coordinates a multidisciplinary team with expertise in epigenetics, immunology, and reproductive biology. Collaborates internationally to advance PCOS research and treatment strategies.

• Endocrinology
• Reproductive Medicine
• Metabolic Disorders
• +6 more

Camilla Svensson is a Professor in Cellular and Molecular Pain Physiology at Karolinska Institutet's Department of Physiology and Pharmacology, leading a research team exploring pain mechanisms in rheumatic diseases and fibromyalgia. She holds academic appointments since 2008, with roles including Wallenberg Scholar and membership in the Young Academy of Sweden. Her work focuses on autoantibody-driven pain pathways, satellite glial cell dysfunction, and neuroimmune interactions in chronic pain syndromes. Educational Background PhD in Molecular Pathology (2005), University of California, San Diego Postdoctoral research in Rheumatoid Arthritis (UCSD) Docent (2015), Karolinska Institutet Research Interests Investigates mechanisms linking autoantibodies to chronic pain, including: Rheumatoid arthritis pain pathways and bone erosion Fibromyalgia immunology: IgG antibodies targeting satellite glial cells Neuroimmune interfaces in spinal cord and dorsal root ganglia Grant Funding Supported by: Swedish Research Council European Commission Wallenberg Academy Fellowships Family Lundblad Foundation Awards Recipient of: Early Career Award (2009) Future Research Leader (2011) Ragnar Söderberg Fellowship (2012) Wallenberg Academy Fellow (2012) Labs & Collaborations Leads a 20-person lab investigating: Human-mouse translational models Organ donor-derived dorsal root ganglia analysis Immunomodulatory drug testing (e.g., Belgian antibody-depleting therapy) Future Work Current studies include: Human satellite glial cell model systems Immunomodulatory treatments for fibromyalgia Neuroimmune biomarker discovery

• Pain Research
• Immunology
• Neurosciences
• +7 more